Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family Study

References

• Weterman IT, Pena AS. Familial incidence of Crohn’s disease in the Netherlands and a review of the literature. Gastroenterology 1984;86:449–52.
   PubMed Web of Science ®Google Scholar
• Farmer RG. Study of family history among patients with inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl:64–8.
   Google Scholar
• Yang H, McElree C, Roth M-P, Shanahan F, Targan SR, Rotter JI. Familial empiric risk for inflammatory bowel disease: differences between Jews and non Jews. Gut 1993;34:517–24.
   Google Scholar
• Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998;115:1066–71.
   PubMed Web of Science ®Google Scholar
• Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456–61.
   PubMed Web of Science ®Google Scholar
• Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107:532–6.
   PubMed Web of Science ®Google Scholar
• Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, et al. Polymorphisms in tumor necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol 1999;34:1025–32.
   PubMed Web of Science ®Google Scholar
• Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A subset of antineutrophil anticytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202–10.
   PubMed Web of Science ®Google Scholar
• Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657–62.
   PubMed Web of Science ®Google Scholar
• Yang P, Janerot G, Danielsson D, Tysk C, Lindberg E. pANCA in monocygotic twins with inflammatory bowel disease. Gut 1995;36:887–90.
   PubMed Web of Science ®Google Scholar
• Lee CW, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995;108:428–33.
   PubMed Web of Science ®Google Scholar
• Stöcker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stocker K, et al. Autoimmunity: pancreatic juice in Crohn’s disease. Scand J Gastroenterol 1987;22:41–52.
   Web of Science ®Google Scholar
• Seibold F, Weber P, Jenss H, Wiedmann KH. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn’s disease. Gut 1991;32:1192–7.
   PubMed Web of Science ®Google Scholar
• Seibold F, Mörk H, Tanza S, Muller A, Holzhuter C, Weber P, et al. Pancreatic autoantibodies in Crohn’s disease: a family study. Gut 1997;40:481–4.
   PubMed Web of Science ®Google Scholar
• Sendid B, Colombel F, Jacquinot PM, Faille C, Fruit J, Cortot A, et al. Specific antibody response to oligomannosidic epitopes in Crohn’s disease. Clin Diag Lab Immunol 1996;3:219–26.
   PubMedGoogle Scholar
• Ruemmele FM, Targan SR, Levy G, Dubinski M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822–9.
   PubMed Web of Science ®Google Scholar
• Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788–91.
   PubMed Web of Science ®Google Scholar
• Malchow H, Ewe K, Brandes JW. European cooperative Crohn’s disease study: result of drug treatment. Gastroenterology 1984;86:249–66.
   Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report of a therapeutic trial. BMJ 1955;ii:1041–8.
   Google Scholar
• Kocourek J, Ballou CE. Method for fingerprinting yeast cell wall mannans. J Bacteriol 1969;100:1175–81.
   PubMed Web of Science ®Google Scholar
• Main J, McKenzie H, Yeaman GR. Antibody to Saccharomyces cerevisiae in Crohn’s disease. BMJ 1988;297:1105–6.
   PubMed Web of Science ®Google Scholar
• Sander U, Kunze I, Bröker M, Kunze G. Humoral immune response to a 200 kDA glycoprotein antigen of Saccharomyces cerevisiae is common in man. Immunol Lett 1998;61: 113–7.
   PubMedGoogle Scholar
• Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn’s disease. Am J Gastroenterol 1998;93:1306–10.
   PubMed Web of Science ®Google Scholar
• Sutton CL, Yang H, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn’s disease. Gut 2000;46:58–63.
   PubMed Web of Science ®Google Scholar
• Seibold F, Brandwein S, Simpson S, Elson CO. pANCA represent a cross-reactivity to enteric bacterial antigens. J Clin Immunol 1998;1823:153–60.
   Google Scholar
• Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. The effect of dietary yeast on the activity of stable Crohn’s disease. Scand J Gastroenterol 1992;27:196–200.
   PubMed Web of Science ®Google Scholar
• McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (Baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut 1990;31:536–8.
   PubMed Web of Science ®Google Scholar
• Lindberg E, Magnusson KE, Tysk C, Järnerot G. Antibody (IgG, IgA and IgM) to baker’s yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobul in in monozygotic twins with inflammatory bowel disease. Gut 1992;33: 909–13.
   Google Scholar
• Vogelsang H, Schwarzenhofer M, Oberhuber G. Changes in gastrointestinal permeability in celiac disease. Dig Dis Sci 1999; 16:333–6.
   Google Scholar
• Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996;26: 934–8.
   Google Scholar